Summary - OGN - NYSE - Weiss Ratings

C

Organon & Co. OGN

$14.60 $0.1451.00%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$13.87 - $23.10

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Biotechnology Consumer Staples Health Care Household Products

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

High-Yield Healthcare: 3 Stocks With Strong Dividends

2/16/2025 - MarketBeat

Analysts Have Conflicting Sentiments on These Healthcare Companies: Fate Therapeutics (FATE), Organon (OGN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

3/6/2025 - TipRanks Financial Blog

Norden Group LLC Invests $307,000 in Organon & Co. (NYSE:OGN)

3/5/2025 - MarketBeat

Bank of New York Mellon Corp Sells 149,081 Shares of Organon & Co. (NYSE:OGN)

3/5/2025 - MarketBeat

Riverview Trust Co Increases Stake in Organon & Co. (NYSE:OGN)

3/2/2025 - Ticker Report

Los Angeles Capital Management LLC Has $1.27 Million Position in Organon & Co. (NYSE:OGN)

3/2/2025 - MarketBeat

A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN)

2/28/2025 - MarketBeat

New York State Common Retirement Fund Increases Stake in Organon & Co. (NYSE:OGN)

2/27/2025 - MarketBeat

Organon & Co. (NYSE:OGN) Trading 5.7% Higher - Still a Buy?

2/25/2025 - MarketBeat

Deseret Mutual Benefit Administrators Raises Stock Position in Organon & Co. (NYSE:OGN)

2/23/2025 - Ticker Report

Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

2/23/2025 - Insider Monkey

10 Cheap Pharmaceutical Stocks to Buy According to Analysts

2/22/2025 - Insider Monkey

State of New Jersey Common Pension Fund D Purchases 42,817 Shares of Organon & Co. (NYSE:OGN)

2/22/2025 - MarketBeat

New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN)

2/21/2025 - MarketBeat

Ex-Dividend Reminder: Organon, Chemed and CNA Financial

2/20/2025 - Dividend Channel

Analysts Anticipate INVN To Hit $23

2/20/2025 - ETF Channel

Savant Capital LLC Lowers Stake in Organon & Co. (NYSE:OGN)

2/19/2025 - MarketBeat

Van ECK Associates Corp Has $7.90 Million Position in Organon & Co. (NYSE:OGN)

2/18/2025 - MarketBeat

Philip James Wealth Mangement LLC Buys 66,341 Shares of Organon & Co. (NYSE:OGN)

2/17/2025 - MarketBeat

Organon's (NYSE:OGN) Dividend Will Be $0.28

2/17/2025 - Simply Wall St

Organon & Co. (NYSE:OGN) Declares Quarterly Dividend of $0.28

2/15/2025 - MarketBeat

Organon & Co. (NYSE:OGN) Shares Down 5.9% Following Weak Earnings

2/15/2025 - MarketBeat

Organon & Co. (NYSE:OGN) Receives Average Recommendation of "Hold" from Analysts

2/15/2025 - MarketBeat

Organon & Co. (NYSE:OGN) Given New $24.00 Price Target at Barclays

2/15/2025 - MarketBeat

Organon & Co. (NYSE:OGN) Price Target Lowered to $16.00 at Morgan Stanley

2/15/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Friday, February 28, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Beginning of May (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

--

52-week Low

Dec 23, 2024 - $13.87

52-week High

Aug 26, 2024 - $23.10

Valuation

Market Cap

$3.73B - Mid Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

www.organon.com

Phone Number

(551) 430-6900

Address

30 Hudson Street
Jersey City, NJ 07302

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the... more